NCT03100071 - Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Cancer PatientsCentral Venous Catheter ThrombosisUpper Extremity Thrombosis

Interventions

DRUG

Apixaban

Patients will be treated with Low Molecular Weight Heparin (LMWH) for 1 week and then with apixaban 5 milligram (mg) twice daily for 11 weeks.

Trial Locations (2)

RECRUITING

London Health Science Center, Victoria Hospital, London

RECRUITING

Ottawa Hospital Research Institute, Ottawa